Cardiovascular research in India: a perspective.

[1]  B. Gupta,et al.  Mapping of Indian neuroscience research: a scientometric analysis of research output during 1999-2008. , 2010, Neurology India.

[2]  Rajeev Gupta,et al.  Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India , 2009, Vascular health and risk management.

[3]  L. Dandona,et al.  Trends of public health research output from India during 2001-2008 , 2009, BMC medicine.

[4]  D. Prabhakaran,et al.  Conduct of clinical trials in developing countries: a perspective , 2009, Current opinion in cardiology.

[5]  V. Ajay,et al.  Prevalence and determinants of diabetes mellitus in the Indian industrial population , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[6]  D. Prabhakaran,et al.  Development of a clinical risk score in predicting undiagnosed diabetes in urban Asian Indian adults: a population-based study , 2008 .

[7]  D. Prabhakaran,et al.  Management of acute coronary syndromes in secondary care settings in Kerala: impact of a quality improvement programme. , 2008, The National medical journal of India.

[8]  S. Yusuf,et al.  Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data , 2008, The Lancet.

[9]  P. Malhotra.  The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India. , 2008, Indian journal of medical ethics.

[10]  S. Yusuf,et al.  Epidemiology and causation of coronary heart disease and stroke in India , 2007, Heart.

[11]  D. Fernando,et al.  A simple valid tool for measuring obesity-related-CHD risk in Sri Lankan adults , 2008 .

[12]  V. Ajay,et al.  Global cardiovascular disease research survey. , 2007, Journal of the American College of Cardiology.

[13]  D. Xavier,et al.  Perspectives on the management of coronary artery disease in India , 2007, Heart.

[14]  Dorairaj Prabhakaran,et al.  Educational status and cardiovascular risk profile in Indians , 2007, Proceedings of the National Academy of Sciences.

[15]  M. Shuchman.  Commercializing clinical trials--risks and benefits of the CRO boom. , 2007, The New England journal of medicine.

[16]  R. M,et al.  Clinical trials in India. , 2007, Pharmacological research.

[17]  Ambady Ramachandran,et al.  Increasing Expenditure on Health Care Incurred by Diabetic Subjects in a Developing Country , 2007, Diabetes Care.

[18]  Bruce Neal,et al.  Chronic diseases now a leading cause of death in rural India--mortality data from the Andhra Pradesh Rural Health Initiative. , 2006, International journal of epidemiology.

[19]  T. Macdonald.  Preventing Chronic Diseases: A Vital Investment , 2006 .

[20]  Anne Mills,et al.  Cardiovascular Disease -- Disease Control Priorities in Developing Countries , 2006 .

[21]  S. Yusuf,et al.  WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). , 2005, Bulletin of the World Health Organization.

[22]  S. Yusuf,et al.  Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2. , 2005, Indian heart journal.

[23]  G. E. Who,et al.  Preventing chronic diseases: a vital investment , 2005 .

[24]  N. Shah.  Ethical Guidelines for Biomedical Research on Human Subjects , 2005 .

[25]  T. Walley,et al.  Monitoring Financial Flows for Health Research. Geneva: Global Forum for Health Research, World Health Organization, 2001. 57pp. ISBN 2-940286- 05-1. [The full text is available on the web site http://www.globalforumhealth.org] , 2002 .

[26]  R. Stott,et al.  The World Bank , 2008, Annals of tropical medicine and parasitology.

[27]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[28]  R. Maheshwari.  Medical education in India. , 1962, Journal of the Indian Medical Association.